CAS 482306-32-1

Rivaroxaban Racemic Mixture

CAS : 482306-32-1

Formule : C₁₉H₁₈ClN₃O₅S

Masse moléculaire : 435.88

Ref: ST-EA-CP-R17021

(±)-Rivaroxaban

Produit contrôlé

CAS : 482306-32-1

Formule : C₁₉H₁₈ClN₃O₅S

Couleur et forme : Neat

Masse moléculaire : 435.881

Ref: TR-R590730

Rivaroxaban

CAS : 482306-32-1

Rivaroxaban is an analog of the kinase inhibitor which has been shown to have potent anticancer activity. It works by inhibiting kinases that are involved in cancer cell growth and survival. Rivaroxaban induces apoptosis in human and Chinese hamster ovary cells, leading to tumor cell death. This drug also inhibits glutathione S-transferase activity, which plays a role in the detoxification of reactive oxygen species and other electrophilic compounds. Rivaroxaban has been found to be effective against a variety of cancer types, including breast, lung, prostate, and colon cancers. It is a promising candidate for use as an anticancer therapy due to its ability to inhibit protein kinases that are overexpressed in cancer cells.

Formule : C₁₉H₁₈ClN₃O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 435.9 g/mol

Ref: 3D-HUA30632